Home
 Portfolio Manager
 Fund
 ETF
 Fund Tools
 Fund Selector
 Funds to Explore
 Category Quickrank
 Guaranteed Funds
 
Snapshot
Chart
Total Return
Portfolio
Rating & Risk
Management
Fees
Manulife China Equity Fund
Performance History
2017-08-31
Growth of $10,000 (MYR)
 
  • Fund
  • 13.67
  • 16.30
  • -1.12
  • 18.93
  • +/-Cat
  • 0.45
  • 1.05
  • -4.73
  • -5.71
  • +/-Idx
  • -1.31
  • 2.63
  • -11.25
  • -9.80
 
 
 
Category: Equity - Greater China
Index: MSCI Golden Dragon NR USD
 
 
  • Trailing Returns(%)
  • 2017-09-19
  • YTD Return
  • 18.06
  • 1 Year
  • 20.87
  • 3 Years Annualised
  • 15.39
  • 5 Years Annualised
  • 15.85
Benchmarks
Fund Benchmark
FTSE AW Greater China TR USD
Morningstar Benchmark
MSCI Golden Dragon NR USD
 
Key Stats
  • Morningstar Category
  • Morningstar Rating™
    (2017-08-31)
  • Equity - Greater China
  • ISIN
  • Inception Date
  • -
  • 2010-01-07
  • NAV(2017-09-19)
  • Day Change
  • MYR 0.8544
  • -0.16%
  • Bid Price
  • Offer Price
  • -
  • -
  • Total Net Assets (Mil)
    (2017-08-31)
  • Total Expense Ratio
    (2016-10-31)
  • USD 10.47
  • 0.55 %
  • Front Load Fee(Max)
  • Redemption Fee
  • 10.00 %
  • 0.00 %
  • Employee Provident Fund
  • Yes
  • Manager Name
  • Start Date
  • Chin Hui Tock
  • 2011-01-07
Advertisement
Investment Objective: Manulife China Equity Fund
 
The fund’s objective is to achieve long term capital growth through investment, primarily in under-valued companies with long term potential and substantial business interest in the Greater China Region which are listed or traded on stock exchanges of Shanghai, Shenzhen, Hong Kong, Taipei or other exchanges.